Presentation is loading. Please wait.

Presentation is loading. Please wait.

PHRM 8660 PHARMACEUTICAL MARKETING RIAN MARIE EXTAVOUR; APRIL 11 TH 2013 TRACKING PROJECT: IMS HEALTH.

Similar presentations


Presentation on theme: "PHRM 8660 PHARMACEUTICAL MARKETING RIAN MARIE EXTAVOUR; APRIL 11 TH 2013 TRACKING PROJECT: IMS HEALTH."— Presentation transcript:

1 PHRM 8660 PHARMACEUTICAL MARKETING RIAN MARIE EXTAVOUR; APRIL 11 TH 2013 TRACKING PROJECT: IMS HEALTH

2 OUTLINE What is IMS Health? What do they do? Sectors served Solutions Timeline and News Report Highlights Conclusion

3 WHAT IS IMS HEALTH? 1 Provider of information, services and technology for healthcare Combine industry expertise to provide perspectives and in-depth analytics on healthcare dynamics Analytics, commercial services and consulting Operations in over 100 countries; process over 4 billion transactions per year Clients: Decision-makers in life sciences, payers, providers, policy-makers

4 FINANCIAL 2 Privately owned – investors (note-holders) Issued full-year 2012 financial results March 4 Conference call on March 8 th Note-holders only

5 WHAT DO THEY DO AND FOR WHO? 1 Tracking of over 80% global pharmaceutical sales activity Over 1.4 million pharmaceutical products 260+ million de-identified patients worldwide 99,000+ suppliers, 768,000 reporting facilities worldwide 5,000 databases supporting 16,000 healthcare clients Healthcare reference assets including 5 million professionals, with 500,000 organizational linkages and 2.4 million affiliations

6 SECTORS SERVED Pharmaceutical Companies – Large and Mid-Sized – Small and Biotech – Generics – Specialty Payers Government Providers Pharmacies Consumer Health Pharmaceutical Distributors Financial Community

7 SOLUTIONS Analytics and Services To optimize commercial effectiveness, clinical decisions and delivery of care Healthcare Measurement Patient, provider and payer insights and market-defining methodologies Consulting Specialized expertise for enabling and accelerating informed decisions

8 IMS INSTITUTE: HEALTH SERVICES RESEARCH NETWORK 3 Academic researchers Including pharmacy, medicine, law, economics, business, public policy Some member institutions: U of Chicago, Columbia U, Harvard U, Mayo Clinic, MIT, St. Jude’s, Stanford Med Sch, U of Illinois Empirical, policy-relevant studies To improve quality and cost-effectiveness of healthcare More than 60 active projects including current aspects of healthcare reform

9 RESEARCH PRIORITIES 3 Drug Utilization Trends and Expenditure Xponent™ - local and regional Rx dispensing data National Sales Perspectives™ National Prescription Audit™ - over 70% all Rx activity National trends; therapies adopted, use and expenditure factors Comparative Effectiveness Research Geographic variations in care Xponent™; NPA Real-world applications

10 HEALTHCARE ANALYTICS AND SERVICES 4 Specialty healthcare analytics Pharma R&D Services Government Solutions Business Process Outsourcing Patient-Centric Solutions – IMS Lifelink™ Pharma Commercial Services Payer Solutions Health Economics and Outcomes Research and Real-world Evidence

11 TIMELINE 5 Founded 1954 by Bill Frolich (ad exec) and David Dubow (visionary) 1957 – first European syndicated study – audit of pharmaceutical sales in West Germany Further studies in Great Britain, France, Italy, Japan; acquisitions in New Zealand, Australia, South Africa 1969 – entered US market; 1970 – Latin America Series of acquisitions of pharmaceutical audit companies; technologies, databases 1972 – becomes a public company 1998 – independent, public NYSE-listed

12 TIMELINE CONT’D 5,6 2010 – taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners Valued at $6 billion 2012 Acquisitions and Collaborations PharmARC (Banglore) analytic services, DecisionView (software solutions); collaborates with Health Intelligence, Inc (BlueCross, BlueShield) Mar 7 2013 – Launches branch in India Leading universities, research institutions, development agencies, government Mar 12 2013 – Acquisition of Appature Software company; cloud-based applications April 4 2013 – IMS Institute for Hcare Informatics Study: Impact of shifting patients to Managed Medicaid Plans

13 MY IMPRESSION Progressive, Innovative Global reach Relevant Responsive to technological and healthcare advances Proactive – expanding/emerging economies If return to public status – INVEST!

14 THANK YOU….QUESTIONS??

15 REFERENCES 1.IMS. Overview. Available at http://www.imshealth.com/portal/site/ims/. Accessed April 2 nd 2013.http://www.imshealth.com/portal/site/ims/ 2. Business Wire. IMS Health to Issue Full-Year 2012 Financial Results on March 4, Conference Call for Note Holders Scheduled for March 8. Available at http://www.businesswire.com/news/home/20130226006405/en/. Accessed Feb 28 2013. http://www.businesswire.com/news/home/20130226006405/en/ 3.IMS. Health Services Research Network. Available at http://www.imshealth.com/portal/site/ims/. Accessed Feb 7 th 2013 http://www.imshealth.com/portal/site/ims/ 4.IMS. Healthcare Analytics and Services. Available at http://www.imshealth.com/portal/site/ims/. Accessed April 2 nd 2013. http://www.imshealth.com/portal/site/ims/ 5.IMS. Company History. Available at http://www.imshealth.com/portal/site/ims/. Accessed April 2 nd 2013. http://www.imshealth.com/portal/site/ims/ 6.IMS. Press Releases. Available at http://www.imshealth.com/portal/site/ims/. Accessed April 2 nd 2013. http://www.imshealth.com/portal/site/ims/


Download ppt "PHRM 8660 PHARMACEUTICAL MARKETING RIAN MARIE EXTAVOUR; APRIL 11 TH 2013 TRACKING PROJECT: IMS HEALTH."

Similar presentations


Ads by Google